Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4192.0
(-2.58%)
JPY 4192.0
(-2.58%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 27.86 Billion JPY | -5.52% |
| 2022 | 29.49 Billion JPY | 9.81% |
| 2021 | 26.85 Billion JPY | -0.81% |
| 2020 | 27.07 Billion JPY | -7.93% |
| 2019 | 29.4 Billion JPY | -15.63% |
| 2018 | 34.85 Billion JPY | -9.57% |
| 2017 | 38.54 Billion JPY | 18.94% |
| 2016 | 32.4 Billion JPY | -24.84% |
| 2015 | 43.11 Billion JPY | 13.36% |
| 2014 | 38.03 Billion JPY | -0.87% |
| 2013 | 38.37 Billion JPY | -9.36% |
| 2012 | 42.33 Billion JPY | -1.63% |
| 2011 | 43.03 Billion JPY | 12.9% |
| 2010 | 38.11 Billion JPY | 7.31% |
| 2009 | 35.52 Billion JPY | -6.09% |
| 2008 | 37.82 Billion JPY | 3.89% |
| 2007 | 36.4 Billion JPY | -10.04% |
| 2006 | 40.47 Billion JPY | -8.23% |
| 2005 | 44.1 Billion JPY | -30.06% |
| 2004 | 63.05 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 32.25 Billion JPY | -0.59% |
| 2023 FY | 27.86 Billion JPY | -5.52% |
| 2023 Q2 | 30.92 Billion JPY | 5.47% |
| 2023 Q1 | 29.32 Billion JPY | -0.59% |
| 2023 Q4 | 27.86 Billion JPY | -1.19% |
| 2023 Q3 | 28.2 Billion JPY | -8.8% |
| 2022 Q3 | 27.06 Billion JPY | 0.52% |
| 2022 Q2 | 26.92 Billion JPY | -1.19% |
| 2022 Q1 | 27.24 Billion JPY | 1.45% |
| 2022 FY | 29.49 Billion JPY | 9.81% |
| 2022 Q4 | 29.49 Billion JPY | 8.97% |
| 2021 Q4 | 26.85 Billion JPY | -4.03% |
| 2021 Q2 | 27.26 Billion JPY | -1.38% |
| 2021 FY | 26.85 Billion JPY | -0.81% |
| 2021 Q1 | 27.64 Billion JPY | 2.09% |
| 2021 Q3 | 27.98 Billion JPY | 2.66% |
| 2020 Q3 | 28.64 Billion JPY | -2.86% |
| 2020 Q1 | 28.52 Billion JPY | -3.02% |
| 2020 Q2 | 29.48 Billion JPY | 3.39% |
| 2020 Q4 | 27.07 Billion JPY | -5.48% |
| 2020 FY | 27.07 Billion JPY | -7.93% |
| 2019 Q4 | 29.4 Billion JPY | -13.16% |
| 2019 FY | 29.4 Billion JPY | -15.63% |
| 2019 Q3 | 33.86 Billion JPY | 8.17% |
| 2019 Q1 | 34.9 Billion JPY | 0.14% |
| 2019 Q2 | 31.3 Billion JPY | -10.3% |
| 2018 Q3 | 33.23 Billion JPY | -5.74% |
| 2018 Q4 | 34.85 Billion JPY | 4.88% |
| 2018 Q2 | 35.25 Billion JPY | -2.74% |
| 2018 Q1 | 36.25 Billion JPY | -5.95% |
| 2018 FY | 34.85 Billion JPY | -9.57% |
| 2017 Q2 | 40.18 Billion JPY | 15.44% |
| 2017 FY | 38.54 Billion JPY | 18.94% |
| 2017 Q4 | 38.54 Billion JPY | 0.88% |
| 2017 Q3 | 38.2 Billion JPY | -4.92% |
| 2017 Q1 | 34.81 Billion JPY | 7.42% |
| 2016 Q1 | 39.35 Billion JPY | -8.72% |
| 2016 Q4 | 32.4 Billion JPY | -15.29% |
| 2016 Q3 | 38.25 Billion JPY | 3.64% |
| 2016 Q2 | 36.91 Billion JPY | -6.21% |
| 2016 FY | 32.4 Billion JPY | -24.84% |
| 2015 Q3 | 44 Billion JPY | 13.66% |
| 2015 Q1 | 36.27 Billion JPY | -4.62% |
| 2015 Q4 | 43.11 Billion JPY | -2.02% |
| 2015 FY | 43.11 Billion JPY | 13.36% |
| 2015 Q2 | 38.71 Billion JPY | 6.72% |
| 2014 Q1 | 37.05 Billion JPY | -3.42% |
| 2014 FY | 38.03 Billion JPY | -0.87% |
| 2014 Q4 | 38.03 Billion JPY | -12.84% |
| 2014 Q2 | 36.78 Billion JPY | -0.74% |
| 2014 Q3 | 43.63 Billion JPY | 18.64% |
| 2013 FY | 38.37 Billion JPY | -9.36% |
| 2013 Q4 | 38.37 Billion JPY | 0.26% |
| 2013 Q3 | 38.27 Billion JPY | 11.81% |
| 2013 Q2 | 34.23 Billion JPY | -19.89% |
| 2013 Q1 | 42.72 Billion JPY | 0.93% |
| 2012 Q3 | 40.9 Billion JPY | -7.75% |
| 2012 Q4 | 42.33 Billion JPY | 3.48% |
| 2012 FY | 42.33 Billion JPY | -1.63% |
| 2012 Q2 | 44.34 Billion JPY | 9.54% |
| 2012 Q1 | 40.48 Billion JPY | -5.93% |
| 2011 Q3 | 42.64 Billion JPY | 13.9% |
| 2011 Q1 | 37.67 Billion JPY | -1.18% |
| 2011 Q2 | 37.44 Billion JPY | -0.6% |
| 2011 Q4 | 43.03 Billion JPY | 0.91% |
| 2011 FY | 43.03 Billion JPY | 12.9% |
| 2010 Q1 | 38.99 Billion JPY | 9.79% |
| 2010 Q2 | 38.55 Billion JPY | -1.14% |
| 2010 FY | 38.11 Billion JPY | 7.31% |
| 2010 Q3 | 43.57 Billion JPY | 13.04% |
| 2010 Q4 | 38.11 Billion JPY | -12.53% |
| 2009 FY | 35.52 Billion JPY | -6.09% |
| 2009 Q3 | 41.46 Billion JPY | 11.73% |
| 2009 Q4 | 35.52 Billion JPY | -14.33% |
| 2009 Q2 | 37.1 Billion JPY | 0.0% |
| 2008 Q4 | 37.82 Billion JPY | -6.56% |
| 2008 FY | 37.82 Billion JPY | 3.89% |
| 2008 Q3 | 40.48 Billion JPY | 0.0% |
| 2007 FY | 36.4 Billion JPY | -10.04% |
| 2006 FY | 40.47 Billion JPY | -8.23% |
| 2005 FY | 44.1 Billion JPY | -30.06% |
| 2004 FY | 63.05 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -11.518% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.644% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 96.291% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 83.045% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -720.8% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 34.996% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 94.369% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -452.897% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 54.832% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | 9.62% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | 29.974% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | 10.353% |
| Tsumura & Co. | 132.88 Billion JPY | 79.03% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | 29.969% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -109.566% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 89.858% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 36.895% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 60.588% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | 40.575% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -297.915% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -9.54% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -242.244% |
| MedRx Co., Ltd | 129 Million JPY | -21501.55% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -751.511% |
| Solasia Pharma K.K. | 673 Million JPY | -4040.565% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -4216.944% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | 11.201% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 83.008% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -2655.354% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 94.682% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -300.815% |